Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution

Neuraminidase inhibitors (NAIs) are the only available licensed therapeutics against human H7N9 influenza virus infections. The emergence of NAI-resistant variants of H7N9viruses with an NA R292K mutation poses a therapeutic challenge. A comprehensive understanding of the susceptibility of these vir...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Emerg Microbes Infect
Prif Awduron: Zhang, Xiaonan, Song, Zhigang, He, Jing, Yen, Hui-Ling, Li, Jianhua, Zhu, Zhaoqin, Tian, Di, Wang, Wei, Xu, Lei, Guan, Wencai, Liu, Yi, Wang, Sen, Shi, Bisheng, Zhang, Wanju, Qin, Boyin, Cai, Jialin, Wan, Yanmin, Xu, Chunhua, Ren, Xiaonan, Chen, Haili, Liu, Lu, Yang, Yuqin, Zhou, Xiaohui, Zhou, Wenjiang, Xu, Jianqing, Zhang, Xiaoyan, Peiris, Malik, Hu, Yunwen, Yuan, Zhenghong
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2014
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274890/
https://ncbi.nlm.nih.gov/pubmed/26038501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emi.2014.80
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg